Home

Katherine A. Eade

CIK 1721318 · last filed 2026-06-12

Katherine A. Eade is a corporate insider who has filed 20 SEC Form 4 insider transactions across 2 companies since 2017. The most recent filing, for HBIO, was dated Jun 12, 2026. Across all open-market trades the lifetime net is +$98.8K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $347.3K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$347.3K

Companies

2

Total Filings

20

Lifetime Open-Market Net

$98.8K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
HBIO Director 58,669 $5.92 $347.3K $98.8K 19 2026-06-12
Vaxxinity, Inc. (VAXX) Delisted Director — $0.11 — $0 1 2023-06-26

Recent Filings

20 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-12 HBIO Grant (A) +16,556 $0 EDGAR
2025-07-18 HBIO Grant (A) +110,000 $0 EDGAR
2024-05-23 HBIO Grant (A) +45,872 $0 EDGAR
2023-06-26 Vaxxinity, Inc. (VAXX) Delisted Grant (A) — $0 EDGAR
2023-05-23 HBIO Grant (A) +25,554 $0 EDGAR
2022-05-26 HBIO Grant (A) +38,259 $0 EDGAR
2022-01-03 HBIO Grant (A) +2,525 $0 EDGAR
2021-12-29 HBIO Grant (A) +1,401 $0 EDGAR
2021-05-27 HBIO Grant (A) +14,400 $0 EDGAR
2021-01-06 HBIO Grant (A) +14,200 $0 EDGAR
Showing 1–10 of 20
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.